Drug Trial

Merck Serono S.A. - Geneva is developing an experimental drug and is currently recruiting SLE patients into a phase II/ III study globally, with 5 research sites across the UK (Manchester Royal Infirmary, University College London Hospitals - London, Whipps Cross University Hospital - London, Royal Hallamshire Hospital - Sheffield, Freeman Hospital - Newcastle).

This study is intended to evaluate how effective this experimental drug is compared to placebo in preventing new flares. For further information please visit:

http://www.clinicaltrials.gov/ct2/show/NCT00624338?cond=%22Systemic+Lupus+Erythematosus%2C+SLE%22&rank=1

If you are interested in participating please discuss this with your Rheumatologist taking this information along with you. Merck Serono has provided a donation to LUPUS UK as a thanks for allowing Merck Serono to display this information.
Add this Add this page to your favorite Social Bookmarking websites(What are these?)
Facebook! Facebook Twitter! Twitter Digg! Digg Reddit! reddit Delicious Delicious StumbleUpon! StumbleUpon
  • PDFDownload page as PDF
  • PrintPrint article